# Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

> **NCT06940427** · PHASE2 · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 50 (estimated)

## Conditions studied

- Fibrosis Lung

## Interventions

- **DRUG:** FAPI tracer
- **DEVICE:** PET/MRI

## Key facts

- **NCT ID:** NCT06940427
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-19
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940427, "Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06940427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*